Advanced search
Publication Cover
Leukemia & Lymphoma Volume 12, 1994 - Issue 5-6
Submit an article Journal homepage
32
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Combination of Mitoxantrone and Etoposide in the Treatment of Myelodysplastic Syndromes Transformed into Acute Myeloid Leukemia

W. U. Knauf Department of Hematology and Oncology, Klinikum Steglitz, Free University, Berlin, Germany
,
W. E. Berdel Department of Hematology and Oncology, Klinikum Steglitz, Free University, Berlin, Germany
,
A. D. Ho University of California San Diego Cancer Center, San Diego, California, USA
,
E.-D. Kreuser Department of Hematology and Oncology, Klinikum Steglitz, Free University, Berlin, Germany
&
E. Thiel Department of Hematology and Oncology, Klinikum Steglitz, Free University, Berlin, Germany
Pages 421-425 | Received 30 May 1993, Published online: 01 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wassim McHayleh, Rajesh Sehgal, Robert L. Redner, Anastasios Raptis, Mounzer Agha, James Natale, The Minh Luong, James J. Schlesselman, Kennteh A. Foon & Michael Boyiadzis. (2009) Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. Leukemia & Lymphoma 50:11, pages 1848-1853.
Read now
Claudia Baldus, Thomas Fietz, Harald Rieder, Stefan Schwartz, Eckhard Thiel & Wolfgang Knauf. (2001) MDR-1 Expression and Deletions of Chromosomes 7 and 5(Q) Separately Indicate Adverse Prognosis in AML. Leukemia & Lymphoma 40:5-6, pages 613-623.
Read now

Articles from other publishers (10)

Simon F Dufresne, Julie Bergeron, Stéphanie Beauchemin, Claire Nour Abou Chakra, Barbara Vadnais, Philippe Bouchard, Annie-Claude Labbé & Michel Laverdière. (2023) Real-life comparison of posaconazole versus fluconazole for primary antifungal prophylaxis during remission-induction chemotherapy for acute leukemia. Journal of the Association of Medical Microbiology and Infectious Disease Canada 8:1, pages 18-28.
Crossref
James T. England, Lalit Saini, Donna Hogge, Donna Forrest, Sujaatha Narayanan, Maryse Power, Thomas Nevill, Florian Kuchenbauer, Monika Hudoba, Artur Szkotak, Joseph Brandwein & David Sanford. (2020) Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort. Clinical Lymphoma Myeloma and Leukemia 20:7, pages e427-e436.
Crossref
S Kayser, A Benner, C Thiede, U Martens, J Huber, P Stadtherr, J W G Janssen, C Röllig, M J Uppenkamp, T Bochtler, U Hegenbart, G Ehninger, A D Ho, P Dreger & A Krämer. (2016) Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Blood Cancer Journal 6:7, pages e449-e449.
Crossref
Steven M. Trifilio, Alfred W. Rademaker, Diane Newman, Katherine Coyle, Katrin Carlson-Leuer, Jayesh Mehta, Jessica Altman, Olga Frankfurt & Martin S. Tallman. (2012) Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia. Leukemia Research 36:4, pages 394-396.
Crossref
Wolfgang Hiddemann, Heinz Huber & Claus R. BartramA. Ganser. 2004. Die Onkologie. Die Onkologie 1815 1846 .
Jeanne E. AndersonKenneth J. KopeckyCheryl L. WillmanDavid HeadMargaret R. O'DonnellFrederick W. LuthardtThomas H. NorwoodI-Ming ChenStanley P. BalcerzakDavid B. JohnsonFrederick R. Appelbaum. (2002) Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study. Blood 100:12, pages 3869-3876.
Crossref
Eric J. Bow, Gilles Gallant, Gaynor J. Williams, Donna Woloschuk, Tsiporah B. Shore, Morel Rubinger & Brent A. Schacter. (1998) Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin. Cancer 83:7, pages 1344-1354.
Crossref
Emel Bayar, Margaret G. Robinson & Thaddeus W. Kurczynski. (1998) Unilateral Retinoblastoma with Acquired Monosomy 7 and Secondary Acute Myelomonocytic Leukemia. Cancer Genetics and Cytogenetics 105:1, pages 79-82.
Crossref
S.A. Johnson & D.S. Richardson. (1998) Anthracyclines in haematology: pharmacokinetics and clinical studies. Blood Reviews 12:1, pages 52-71.
Crossref
Marc A. Boogaerts, Gregor E.G. Verhoef & Hilde Demuynck. (1996) 9 Treatment and prognostic factors in myelodysplastic syndromes. Baillière's Clinical Haematology 9:1, pages 161-183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.